NC State study finds facial itch follows a different neural path: full analysis

A new NC State study suggests the face has its own rules for itch. In research published May 2, 2026, in Communications Biology, investigators found that facial itch is processed differently from body itch because trigeminal pathways in the head and face engage different neuropeptide signaling and nociceptive circuits than the spinal pathways used elsewhere in the body. The work helps explain why itch intensity and quality can vary by body region, and why facial itch may be harder to map neatly onto what’s known from trunk and limb models. (news.ncsu.edu)

That question has been building for years. Itch biology has increasingly moved away from the older idea that itch is simply a low-grade form of pain, with prior research showing specialized itch circuits in peripheral nerves, the spinal cord, and the brain. Reviews of the field have also emphasized that itch signals arise from either dorsal root ganglia for the body or trigeminal ganglia for the face, but the regional consequences of that split have remained less clear. NC State’s new paper takes that anatomical distinction and tests whether it translates into meaningfully different itch processing. (nih.gov)

In the study, the researchers compared histamine-evoked itch in mice on the cheek versus the nape of the neck. They found lower itch responses in the cheek, then looked beyond simple anatomy to ask whether the difference was structural or molecular. According to the university’s release and the paper abstract, peripheral innervation density did not explain the gap. Instead, the team identified divergence in neuropeptide signaling between trigeminal and spinal systems, along with a distinct population of trigeminal neurons involved in itch-pain coding. The authors report that histamine receptors HRH1 and HRH3 contributed to mixed itch-and-pain sensations, while substance P- and somatostatin-expressing neurons shaped the shift in the cheek by recruiting distinct nociceptive circuits in the brainstem. (news.ncsu.edu)

NC State’s release offers a more clinician-friendly framing of the mechanism. In dorsal root ganglia, the researchers describe separate pain and itch pathways associated with substance P and B-type natriuretic peptide, respectively. In trigeminal ganglia, by contrast, they found three possible signaling routes, including one in which both peptides are expressed. In that overlapping facial pathway, substance P appeared to be overproduced relative to itch signaling, effectively pushing the sensory experience away from itch and toward pain-like processing. Lead investigator Santosh Mishra said the team’s next step is to determine why substance P is overproduced in that setting. (news.ncsu.edu)

Outside reaction was limited in the immediate coverage available, but the findings fit with broader itch literature that has already highlighted substance P as a plausible therapeutic target in chronic pruritus and somatostatin as an important mediator at the itch-pain interface. Prior work has shown that these molecules can shape whether incoming sensory information is experienced as itch, pain, or a mixed signal, which makes the NC State findings biologically plausible and potentially relevant beyond a single experimental model. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary teams, this is basic science with practical implications. Companion animals with facial pruritus often present in diagnostically messy ways, with overlap among dermatologic disease, otic disease, neuropathic conditions, dental or oral pain, and compulsive or self-traumatic behaviors. If facial itch is filtered through partially distinct trigeminal circuitry, that could help explain why some patients show disproportionate rubbing, dysesthesia, or pain-like behaviors despite limited visible skin disease. It also reinforces a broader clinical point: body location may not be a minor detail in pruritus workups or future treatment design. (news.ncsu.edu)

The veterinary angle is also notable because the paper includes investigators from NC State’s College of Veterinary Medicine, including pain researcher B. Duncan X. Lascelles and veterinary dermatologist Thierry Olivry. That doesn’t make the findings immediately practice-changing, but it does suggest the work sits at the intersection of comparative neurology, pain science, and dermatology, where translational relevance to animal patients is a real possibility. The study was supported by an NIH grant, and the authors reported no competing interests in the journal version currently available online. (news.ncsu.edu)

What to watch: The key question now is translational: whether these trigeminal-specific itch-pain mechanisms can be leveraged into region-specific therapies, and whether follow-on work in naturally occurring disease will show similar patterns in veterinary patients with facial pruritus, neuropathic itch, or chronic pain syndromes. (news.ncsu.edu)